Ritholtz Wealth Management Regeneron Pharmaceuticals, Inc. Transaction History

Ritholtz Wealth Management

$3.29 Billion
Q1 2025

A detailed history of Ritholtz Wealth Management transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Ritholtz Wealth Management holds 486 shares of REGN stock, worth $287,639. This represents 0.01% of its overall portfolio holdings.

Number of Shares

486

Previous 451 7.76%

Holding current value

$287,639

Previous $321,000 4.05%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 16, 2025	BUY	$634.14 - $744.83 $22,194 - $26,069	35 Added 7.76%	486 $308,000
Q4 2024 Jan 14, 2025	SELL	$701.85 - $1046.91 $195,114 - $291,040	-278 Reduced 38.13%	451 $321,000
Q3 2024 Oct 10, 2024	BUY	$1024.09 - $1201.76 $111,625 - $130,991	109 Added 17.58%	729 $766,000
Q2 2024 Jul 31, 2024	BUY	$883.2 - $1071.19 $47,692 - $57,844	54 Added 9.54%	620 $651,000
Q1 2024 Apr 24, 2024	BUY	$902.69 - $993.35 $62,285 - $68,541	69 Added 13.88%	566 $544,000
Q4 2023 Jan 18, 2024	SELL	$775.18 - $881.7 $10,077 - $11,462	-13 Reduced 2.55%	497 $436,000
Q3 2023 Oct 13, 2023	BUY	$692.45 - $844.37 $54,703 - $66,705	79 Added 18.33%	510 $419,000
Q2 2023 Jul 14, 2023	SELL	$700.03 - $830.35 $44,801 - $53,142	-64 Reduced 12.93%	431 $309,000
Q1 2023 Apr 19, 2023	SELL	$680.49 - $826.97 $10,887 - $13,231	-16 Reduced 3.13%	495 $406,000
Q4 2022 Jan 18, 2023	SELL	$705.89 - $766.39 $745,419 - $809,307	-1,056 Reduced 67.39%	511 $0
Q3 2022 Oct 18, 2022	BUY	$573.97 - $724.32 $492,466 - $621,466	858 Added 121.02%	1,567 $1.08 Million
Q2 2022 Jul 15, 2022	BUY	$548.35 - $738.84 $22,482 - $30,292	41 Added 6.14%	709 $419,000
Q1 2022 Apr 14, 2022	BUY	$595.12 - $698.43 $37,492 - $44,001	63 Added 10.41%	668 $467,000
Q4 2021 Jan 18, 2022	BUY	$543.48 - $670.97 $1,630 - $2,012	3 Added 0.5%	605 $382,000
Q3 2021 Oct 14, 2021	SELL	$574.03 - $680.96 $23,535 - $27,919	-41 Reduced 6.38%	602 $364,000
Q2 2021 Jul 20, 2021	BUY	$472.8 - $558.54 $4,728 - $5,585	10 Added 1.58%	643 $359,000
Q1 2021 May 12, 2021	BUY	$446.73 - $548.2 $10,274 - $12,608	23 Added 3.77%	633 $299,000
Q4 2020 Jan 19, 2021	BUY	$478.3 - $607.98 $7,652 - $9,727	16 Added 2.69%	610 $295,000
Q3 2020 Oct 23, 2020	SELL	$544.75 - $658.21 $164,514 - $198,779	-302 Reduced 33.71%	594 $333,000
Q2 2020 Jul 15, 2020	BUY	$493.32 - $643.92 $47,358 - $61,816	96 Added 12.0%	896 $559,000
Q2 2019 Jul 15, 2019	SELL	$299.6 - $414.82 $9,886 - $13,689	-33 Reduced 3.96%	800 $250,000
Q1 2019 Apr 12, 2019	BUY	$372.08 - $439.57 $12,278 - $14,505	33 Added 4.13%	833 $342,000
Q1 2018 Apr 17, 2018	BUY	$315.82 - $393.78 $252,656 - $315,024	800 New	800 $275,000

Others Institutions Holding REGN

# of Institutions

1,470

Shares Held

85.8M

Call Options Held

1.39M

Put Options Held

1.45M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $63.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ritholtz Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Ritholtz Wealth Management with notifications on news.

Account

Ritholtz Wealth Management Regeneron Pharmaceuticals, Inc. Transaction History